Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.43 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | SELE | P16581 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | MPI | P34949 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL564668 | 0.84 | SELL (0.38) | SELLSELPSELEACHEKDM4E | |
| SCHEMBL19880436 | 0.84 | SELL (0.38) | SELLSELPSELEACHEKDM4E | |
| SCHEMBL27804340 | 0.82 | SELL (0.36) | SELLSELPSELEACHEKDM4E | |
| SCHEMBL374990 | 0.79 | ACHE (0.43) | SELLSELPSELEACHEKDM4E | |
| SCHEMBL30413280 | 0.79 | ACHE (0.43) | SELLSELPSELEACHEKDM4E | |
| SCHEMBL20621268 | 0.78 | HSD17B10 (0.41) | SELLSELPSELEACHEALDH1A1 | |
| SCHEMBL19880474 | 0.78 | CYP3A4 (0.39) | SELLSELPSELEALDH1A1MAPT | |
| SCHEMBL19880477 | 0.77 | PTGS1 (0.33) | SELLSELPSELE | |
| SCHEMBL5509678 | 0.75 | CES2 (0.38) | SELLSELPSELEKDM4EMAPT | |
| Methyl Alcohol SCHEMBL9652269 | 0.75 | CA1 (0.40) | SELLSELPSELEACHEPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820862-B2 | Ligand, method for producing the same, and catalyst using the ligand | THE UNIVERSITY OF TOKYO (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20090023579-A1 | Ligand, Method for Producing the Same, and Catalyst Using the Ligand | THE UNIVERSITY OF TOKYO (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1995250-A1 | LIGAND, METHOD FOR PRODUCING THE SAME, AND CATALYST USING THE LIGAND | The University of Tokyo (JP) | 2008-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023579-A1 | Ligand, Method for Producing the Same, and Catalyst Using the Ligand | CHRM1, CHRM2, B3GNT2 | SELL 186/4885SELP 620/4885SELE 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.